Medicare Enrolled

Dr. Jeffrey English, M.D.

Neurological Surgery · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3200 DOWNWOOD CIR NW STE 550, Atlanta, GA 30327
4043510205
In practice since 2005 (20 years)
NPI: 1508856790 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. English from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. English? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. English

Dr. Jeffrey English is a neurological surgery specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. English performed 18,183 Medicare services across 918 unique beneficiaries.

Between the years covered by Open Payments, Dr. English received a total of $826,555 from 44 pharmaceutical and/or device companies across 1046 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurological surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. English is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in GA $826,555 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,183
Medicare services
Top 1% in GA for neurological surgery
918
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~909 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
17,000 $5 $7
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
570 $88 $139
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
225 $60 $98
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
103 $127 $199
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
60 $155 $297
New patient office visit, complex (60-74 min) 55 $160 $234
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
50 $99 $194
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $123 $174
MRI of upper spine without contrast
An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine.
41 $105 $285
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
33 $25 $36
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$826,555
Total received (2018-2024)
Avg $118,079/year across 7 years
Top 5% in GA for neurological surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,046
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$746,095 (90.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$76,132 (9.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,327 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$101,411
2023
$106,457
2022
$118,332
2021
$88,361
2020
$74,188
2019
$186,698
2018
$151,108

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$46,376
Biogen, Inc.
$17,847
E.R. Squibb & Sons, L.L.C.
$13,172
Amgen Inc.
$8,492
Genentech USA, Inc.
$7,457
TG Therapeutics, Inc.
$3,834
Celgene Corporation
$2,919
ABBVIE INC.
$228
Novartis Pharmaceuticals Corporation
$182
Alexion Pharmaceuticals, Inc.
$177
Eisai Inc.
$143
Lilly USA, LLC
$97
ACADIA Pharmaceuticals Inc
$72
ARGENX US, INC.
$54
PFIZER INC.
$54
Amneal Pharmaceuticals LLC
$48
MDD US Operations, LLC
$44
Teva Pharmaceuticals USA, Inc.
$36
Boston Scientific Corporation
$36
Alnylam Pharmaceuticals Inc.
$28
Axsome Therapeutics, Inc.
$22
Cycle Pharmaceuticals Inc
$21
Lundbeck LLC
$20
UCB, Inc.
$19
BANNER LIFE SCIENCES, LLC
$18
LivaNova USA, Inc.
$14
Top 3 companies account for 76.3% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$310,050
EMD Serono, Inc.
$231,960
GENZYME CORPORATION
$110,238
E.R. Squibb & Sons, L.L.C.
$59,421
Celgene Corporation
$37,552
Horizon Therapeutics plc
$21,237
Teva Pharmaceuticals USA, Inc.
$16,344
Genentech USA, Inc.
$10,659
Amgen Inc.
$8,505
Mallinckrodt LLC
$7,882
TG Therapeutics, Inc.
$3,834
Genentech, Inc.
$2,510
AbbVie Inc.
$2,171
Novartis Pharmaceuticals Corporation
$1,191
ABBVIE INC.
$586
Alexion Pharmaceuticals, Inc.
$465
PFIZER INC.
$223
Supernus Pharmaceuticals, Inc.
$211
ACADIA Pharmaceuticals Inc
$210
Eisai Inc.
$143
Lilly USA, LLC
$136
TG THERAPEUTICS, INC.
$129
SK Life Science, Inc.
$125
Amneal Pharmaceuticals LLC
$89
BOSTON SCIENTIFIC CORPORATION
$83
Neurelis, Inc.
$72
ARGENX US, INC.
$70
Neurocrine Biosciences, Inc.
$55
UCB, Inc.
$52
MDD US Operations, LLC
$44
LivaNova USA, Inc.
$36
Boston Scientific Corporation
$36
Alnylam Pharmaceuticals Inc.
$28
Exeltis, USA Inc.
$25
Biohaven Pharmaceutical Holding Company Ltd.
$23
Axsome Therapeutics, Inc.
$22
Cycle Pharmaceuticals Inc
$21
Lundbeck LLC
$20
JAZZ PHARMACEUTICALS INC.
$20
Mallinckrodt Hospital Products Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
BANNER LIFE SCIENCES, LLC
$18
Greenwich Biosciences, Inc.
$14
SANOFI-AVENTIS U.S. LLC
$8
Top 3 companies account for 78.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMVUTTRA · AUBAGIO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · BodyGuardian · Briviact · COMIRNATY · COPAXONE · EMGALITY · EPIDIOLEX · Epidiolex · FLUMIST QUADRIVALENT · GILENYA · General - Pain Management · Gocovri · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MS DISEASE STATE · Mavenclad · NUPLAZID · NURTEC ODT · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ozanimod · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · QULIPTA · RYTARY · Rebif · Rystiggo · SOLIRIS · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Tascenso ODT · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vumerity · XCOPRI · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurological surgery and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurological surgery in GA.

Looking for a neurological surgery specialist in Atlanta?
Compare neurological surgerists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse neurological surgerists nearby

Geographic Context

Neurological surgerists within 10 mi
100
Per 100K population
9.4
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. English is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with speaking/promotional industry engagement in the top 5% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. English experienced with botox injection, per unit?
Based on Medicare claims data, Dr. English performed 17,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. English receive payments from pharmaceutical companies?
Yes. Dr. English received a total of $826,555 from 44 companies across 1,046 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. English's costs compare to other neurological surgerists in Atlanta?
Dr. English's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. English) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →